[
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day",
    "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=229946c2a0f9b7dace4e55ea8f07d35c01d0d3899c52a89e21f4d255f95fbadb",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733935260,
      "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day",
      "id": 131936103,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=229946c2a0f9b7dace4e55ea8f07d35c01d0d3899c52a89e21f4d255f95fbadb"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals: Progress Check Suggests Stock Remains A Solid Buy",
    "summary": "Vertex Pharmaceuticals Incorporated looks set for two new drug approvals in early 2025. Click here to read an analysis of VRTX stock now.",
    "url": "https://finnhub.io/api/news?id=4597368d7a05f3acaa729df63fc7000c7e7b7b17fdbe675cedc4743ecf41c4a8",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733918173,
      "headline": "Vertex Pharmaceuticals: Progress Check Suggests Stock Remains A Solid Buy",
      "id": 131920823,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1395424721/image_1395424721.jpg?io=getty-c-w1536",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "Vertex Pharmaceuticals Incorporated looks set for two new drug approvals in early 2025. Click here to read an analysis of VRTX stock now.",
      "url": "https://finnhub.io/api/news?id=4597368d7a05f3acaa729df63fc7000c7e7b7b17fdbe675cedc4743ecf41c4a8"
    }
  }
]